Winton Group’s Zomedica Corp. ZOM Stock Holding History

Winton Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,390,248	Closed	-$321K	–	1490
2020 Q4	$321K	Buy	1,390,248 +672,366	+94%	+$85.7K	0.02%	1011
2020 Q3	$79K	Buy	+717,882	New	+$98.9K	﹤0.01%	1424

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Winton Group's ZOM Position: Q1 2021 in Review

Winton Group sold out of Zomedica Corp. (ZOM) in Q1 2021, closing a stake of 1,390,248 shares — an estimated $321K sold.

Winton Group first reported a position in ZOM in Q3 2020 and held it in 2 quarters. The position peaked at $321K in Q4 2020. 102 funds tracked by Wall St. Rank hold ZOM as of Q1 2021.

Winton Group reported no remaining Zomedica Corp. position as of Q1 2021 after selling out during the quarter.
Winton Group sold 1,390,248 Zomedica Corp. shares in Q1 2021, an estimated $321K.
Winton Group first reported a position in Zomedica Corp. in Q3 2020 and held it in 2 quarters.
Winton Group's Zomedica Corp. position peaked at $321K in Q4 2020.
102 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2021.

Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.